CryoPort ( (CYRX) ) just unveiled an update.
On March 31, 2025, Cryoport, Inc. announced the sale of its global specialty courier business, CRYOPDP, to DHL Supply Chain International Holding B.V. for approximately $138 million in cash, based on a total enterprise value of $195 million. This transaction, expected to close in the second or third quarter of 2025, will enhance DHL’s capabilities in specialized pharma logistics and supports its strategy to lead in life science and healthcare logistics. The strategic partnership between Cryoport and DHL aims to strengthen their supply chain service offerings for the global life sciences and healthcare sector, with Cryoport focusing on expanding its business in EMEA and APAC regions.
More about CryoPort
Cryoport, Inc. is a global leader in supply chain solutions for the life sciences sector, focusing on cell and gene therapies. The company provides a wide range of supply chain solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems. Headquartered in Nashville, Tennessee, Cryoport operates over 50 global locations across 17 countries.
YTD Price Performance: -23.68%
Average Trading Volume: 402,651
Technical Sentiment Signal: Buy
Current Market Cap: $304M
See more insights into CYRX stock on TipRanks’ Stock Analysis page.